Valeant Pharmaceuticals International Inc, recently bought the rights to Nitropress and Isuprel, two life-saving heart drugs, and the same day increased their prices by 525% and 212%. Are patients getting better quality drugs? No. Were the drugs improved upon in any way? No. What changed with the drugs? Just the ownership- and that difference, Valeant Pharmaceuticals believes, justifies a price increase of up to 525%. Do you agree? Read more here. (Source: Jonathan Rockoff and Ed Silverman, WSJ Business, 4/26/15)
You are here: / / Why Has Valeant Increased Prices of Life Saving Heart Drugs by up to 525%?